ClinicalTrials.govpublic full text
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
cystic fibrosis, bacterial infections, cardiovascular and respiratory diseases, genetic diseases and dysmorphic syndromes, immunologic disorders and infectious disorders, rare disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903761
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.